1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Sources
2.3. Research Design
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL GENOMICS MARKET BY APPLICATION
5.1. Introduction
5.2. Drug Discovery and Development
5.3. Diagnostics
5.4. Precision Medicine
5.5. Agriculture and Animal Research
5.6. Other Applications
6. GLOBAL GENOMICS MARKET BY END-USER
6.1. Introduction
6.2. Hospitals & clinics
6.3. Research centers & Government Institutes
6.4. Pharmaceutical & Biotechnology Companies
6.5. Others
7. GLOBAL GENOMICS MARKET BY TECHNOLOGY
7.1. Introduction
7.2. PCR
7.3. Sequencing
7.4. Microarray
7.5. Nucleic Acid Extraction and Purification
7.6. Others
8. GLOBAL GENOMICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East And Africa
8.5.1. Saudi Arabia
8.5.2. Israel
8.5.3. Other
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Taiwan
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Illumina, Inc
10.2. Thermo Fisher Scientific, Inc.
10.3. Qiagen
10.4. Bio-Rad Laboratories, Inc.
10.5. Danaher
10.6. BGI Genomics
10.7. F. Hoffmann-La Roche
10.8. Merck KGaA
10.9. Integrated DNA Technologies, Inc.
10.10. Agilent Technologies, Inc.
LIST OF FIGURES
LIST OF TABLES